Eric Sullivan

Insider Reports History

Entity
Individual
Location
Goodwin Procter Llp, 53 State St, Boston, MA
Signature
/s/ Margaret Siegel as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric Sullivan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TCR2 THERAPEUTICS INC. Chief Financial Officer Restricted Stock Unit (Right to Buy) 6.8K Dec 15, 2022 Direct
TCR2 THERAPEUTICS INC. Chief Financial Officer Restricted Stock Unit 0 Jun 1, 2023 Direct
TCR2 THERAPEUTICS INC. Chief Financial Officer Stock Option (Right to Buy) 0 $0.74 Jun 1, 2023 Direct

Insider Reports Filed by Eric Sullivan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TCRR TCR2 THERAPEUTICS INC. Jun 1, 2023 3 $0 4 Jun 1, 2023 Chief Financial Officer
TCRR TCR2 THERAPEUTICS INC. Dec 15, 2022 2 $0 4 Dec 19, 2022 Chief Financial Officer
TCRR TCR2 THERAPEUTICS INC. Jun 27, 2022 1 $0 4 Jun 27, 2022 Chief Financial Officer
TCRR TCR2 THERAPEUTICS INC. Jun 27, 2022 0 $0 3 Jun 27, 2022 Chief Financial Officer